Speakers

Tamar Grossman

VP, Global Head of RNA & Targeted Therapeutics

Johnson & Johnson

Jacob Sten Petersen

SVP Global Nucleic Acid Therapeutics

Novo Nordisk

Michelle Werner

CEO

Alltrna

Geeta Vemuri

Founder & Managing Partner

Agent Capital

Amy Rappaport

Associate Vice President, Translational Immunology

Gritstone Bio

Gene Yeo

Professor

University Of California San Diego

Stefan McDonough

SVP Neuroscience

Atalanta Therapeutics

Maire Jung

VP & CSO, RNA

Eli Lilly

Roberta Duncan

Chief Strategy Officer

Arcturus Therapeutics

Paris Aliahmad

Head of Research and Development

Replicate Bioscience

Örn Almarsson

CEO

Axelyf

Clay Alspach

Executive Director

Alliance for mRNA Medicines

Sam Alworth

CEO

AcuraStem

Matt Angel

CEO

Factor Bioscience

Jory Bell

General Partner

Playground Global

Jacob Borrajo

CEO

Amber Bio

Bhawanjit Brar

CEO

Jaan Biotherapeutics

Phil Challis

SVP Manufacturing

etherna

Todd Chappell

COO

Korro Bio

Charles Chase

VP, Technical Business Development

Asymchem

Eunji Chung

Associate Professor

University of Southern California

Eric Dai

Investor

Dimension Capital

Erik Digman Wiklund

CEO

Circio

Scott Dindot

Executive Director of Molecular Genetics

Ultragenyx Pharmaceutical

Gilles Divita

CSO at Aanastra/ CEO

Divincell SAS

Ramana Doppalapudi

VP, Chemistry

Avidity Biosciences

Steven Dowdy

Professor

University California San Diego

Wayne Doyle

Head of Platform

Eclipse Bioinnovations

Denis Drygin

SVP R&D

Nosis Biosciences

Christine Esau

VP, Biology

Arrowhead Pharmaceuticals

Daniel Fischer

CEO

Tevard Biosciences

Brendan Frey

Founder and CIO

Deep Genomics

Miroslav Gasparek

CEO

Sensible Biotechnologies

Ann Gidner

CEO

Ziccum

Jarret Glasscock

CEO

Cofactor Genomics

Taryn Goode

Head of Life Sciences

Connect

Rachel Groppo

Director, mRNA Research & Discovery

Johnson & Johnson

Shuling Guo, PhD

Vice President, Antisense Drug Discovery

Ionis Pharmaceuticals

Yacoub Habib

CEO

Ophidion

Trevor Hallam

CSO

Sail Biomedicines

Vignesh Hariharan

Post Doctoral Associate

University of Massachusetts

Christopher Hart

Co-Founder & CEO

Creyon Bio

Michael Hodges

CEO

1strand San Diego County RNA cluster

Allen Horhota

VP, RNA Sciences

ORNA Therapeutics

David Huss

CSO

Shape Therapeutics

Stuart Hwang

Partner

Remiges Ventures

David Katzmann

Sr. Fellow in Mechanistic Pharmacology

Arrowhead Pharmaceuticals

Rabia Khan

CEO

Serna Bio

Stephanie Khan

Director, Business Development

Ginkgo BioWorks

Aki Ko

CEO

Elixirgen Therapeutics

Andreas Kuhn

SVP RNA Biochemistry & CMC Management

BioNTech SE

Arthur Levin

Strategic Leader

Avidity Biosciences

Sophia Lugo

CEO

Radar Therapeutics

Tim Luker

VP Ventures

Eli Lilly & Company

Stefan Lutz

Senior Vice President, Research

Codexis

James McArthur

CEO

PepGen

Zdravka Medarova

CSO

TransCode Therapeutics

Rudi Micheletti

Director of Biology and Functional Genomics

HAYA Therapeutics

Mathew Miller

Director, Life Science & RNA Technology

Codexis

Sanjay Mistry

VP Venture Investments

Johnson & Johnson Innovation

Nicholas Mourlas

Head of Johnson & Johnson Innovation, JLABS San Diego

Johnson & Johnson

Brad Niles

CEO

Ariz Precision Medicine

Anders Näär

Professor of Metabolic Biology

UC Berkeley

Jade Osei-Tutu

Head of RNA Leaders, Senior Conference Director

LSX

Samir Ounzain

CEO

HAYA Therapeutics

Carter Palmer

CEO

Third Element Bio

Hari Pujar

COO

Tessera Therapeutics

Raj Reddy

CEO

Canary Cure

Baley Reeves

Director

National Center for Therapeutics Manufacturing

Diane Retallack

COO

Primrose Bio

Syed Reza

Scientific & Sales Consultant

NOF Corporation

Kasper Roet

CEO and Founder

QurAlis

Kent Rogers

Partner

ARCH Venture Partners

Katherine Rothamel

Associate Director RNA Center for Technologies and Therapeutics

University of California San Diego

Dr. Babak Sanii

Associate Director of Biochip R&D

Nutcracker Therapeutics

Samantha Sarni

Senior Scientist

Regeneron

Ashish Sarode

Director, Delivery and Formulations, mRNA Center of Excellence (CoE)

Sanofi

Sirat Sikka

Senior Scientist, Applications & Innovation

Thermo Fisher Scientific

Kevin Skol

CBO

Arcturus

David Slack

CEO

Impilo Therapeutics

Uli Stilz

Head of Bio Innovation Hub

Novo Nordisk Bio Innovation Hub

Eduardo Velasquez

Senior Director, Research & Economic Development

San Diego Regional EDC

Garrett Vygantas

Managing Partner

Riverine Ventures

Amy Walker

VP of Research & Business Development

4Basebio

Tony Walshe

Director of Research

Alnylam Pharmaceuticals

Nathaniel Wang

CEO

Replicate Bioscience

Weimin Wang

CEO

Sanegene Bio

Jim Weterings

VP Research, RNA Therapeutics & Delivery

Sirnaomics

Leslie Williams

CEO

hC Bioscience

Renee Williams

Managing Partner

Williams Biotech Consulting, LLC

Simon Xi

CEO

Rgenta Therapeutics

Raymond Yang

Unchained Labs

Stefano Zanotti

Head of Neuromuscular Research

Dyne Therapeutics

Qing Zhang

Partners

LDV Partners

Weiyi Zhang

CEO & CSO

RiboX Therapeutics

Sheng Zhong

Professor

University of California San Diego

Qiong Zhou

Executive Director of Discovery Biology Unit

WuXi AppTec

John Zuris

Director, Editing Technologies

Editas Medicine